西奈山医院采用Flosonics Medical的液体监测可穿戴设备-动脉网

Mount Sinai Hospital adopts Flosonics Medical’s fluid monitoring wearable

Medical Device Network 等信源发布 2025-06-17 15:07



可切换为仅中文







The Mount Sinai rollout marks Flosonics’s first deployment on the US East Coast. Image credit: Flosonics.

西奈山的推出标志着Flosonics首次在美国东海岸部署。图片来源：Flosonics。

Mount Sinai has become the first hospital to implement FloPatch, a wearable device designed by Canada-based Flosonics Medical to monitor blood flow in its intensive care units (ICU).

西奈山医院已成为首家实施FloPatch的医院，这款由加拿大Flosonics Medical设计的可穿戴设备用于监测其重症监护室（ICU）中的血流。

The FloPatch enables ICU clinicians to perform haemodynamic assessments to guide intravenous (IV) fluid management and mitigate issues arising from excess fluid intake for patients with conditions such as sepsis, and in post-surgical care, wherein fluid boluses are often used to treat hypotension.

FloPatch使ICU临床医生能够进行血流动力学评估，以指导静脉(IV)液体管理，并缓解因过量摄入液体而引发的问题，例如在脓毒症患者及术后护理中，常使用液体推注来治疗低血压的情况。

Post-surgery, many patients are not fluid responsive and may face adverse effects from unnecessary fluids, leading to complications and longer hospital stays. The provision of unnecessary fluids to patients post-surgery can include pulmonary oedema, heart failure, and abdominal compartment syndrome.

术后，许多患者对液体补充无反应，并且可能因不必要的液体补充而面临不良反应，导致并发症和住院时间延长。术后为患者提供不必要的液体会引起肺水肿、心力衰竭和腹腔室隔综合征等并发症。

Research indicates that .

研究表明，。

excess fluid can also

多余的液体也会

impair tissue healing, thereby heightening the risk of wound infections and anastomotic leakage.

损害组织愈合，从而增加伤口感染和吻合口漏的风险。

FloPatch received 510(k) clearance from the US Food and Drug Administration (FDA) in 2023.

FloPatch 在 2023 年获得了美国食品药品监督管理局 (FDA) 的 510(k) 许可。

Since introducing FloPatch, Mount Sinai clinicians have reportedly used it to bring greater precision to fluid therapy, moving “beyond protocolised care to personalised decisions grounded in real-time patient data”. According to early internal data from the hospital, 42% of patients assessed with FloPatch since its introduction were found to be unresponsive to fluids..

自从引入FloPatch以来，据报道，西奈山的临床医生已经使用它为液体治疗带来了更高的精确度，实现了“超越协议化护理，基于实时患者数据做出个性化决策”。根据该医院早期的内部数据，自FloPatch引入以来，使用其评估的患者中有42%被发现对液体无反应。

Dr John Oropello, professor of surgery and medicine at the Icahn School of Medicine at Mount Sinai and director of the transplant ICU at Mount Sinai, commented: “The wireless ultrasound device addresses a longstanding need in critical care for accessible and repeatable assessments to understand a patient’s fluid responsiveness at the bedside.

约翰·奥罗佩洛博士，西奈山伊坎医学院的外科学和医学教授，同时也是西奈山移植重症监护室的主任，评论道：“无线超声设备解决了重症监护中长期以来对便捷且可重复评估的需求，以便在床边了解患者的液体反应性。”

It allows our team to make timely, physiologically guided decisions in complex, high-acuity situations.”.

它使我们的团队能够在复杂、高危的情况下及时做出基于生理学指导的决策。

GlobalData Strategic Intelligence

全球数据战略情报

US Tariffs are shifting - will you react or anticipate?

美国关税正在变化——你会做出反应还是提前预测？

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

不要让政策变化让你措手不及。通过实时数据和专家分析保持主动性。

By GlobalData

全球数据

Learn more about Strategic Intelligence

了解有关战略情报的更多信息

In March 2025, Flosonics

2025年3月，Flosonics

completed a C$7.5m ($5.18m) venture debt fundraising round

完成了750万加元（518万美元）的风险债务融资回合

from financial solutions provider RBCx to expedite the wearable in the market. The device company added that its device’s adoption by Mount Sinai, which follows rollouts by healthcare systems, including California-based

来自金融服务提供商RBCx，以加快可穿戴设备上市。该设备公司补充道，其设备已被西奈山医院采用，此前已有一系列医疗系统推出，包括位于加利福尼亚的系统。

Sutter Health

萨特健康

and

和

Riverside University Health System

河滨大学健康系统

, marks its first on the US East Coast.

，标志着它在美国东海岸的首次亮相。

According to GlobalData analysis, the overall global patient monitoring segment, of which Flosonics’ wearable is a part, will reach a valuation of around $25.6bn by 2034, up from $21.4bn in 2024.

根据 GlobalData 的分析，Flosonics 可穿戴设备所属的全球患者监测领域整体规模预计将在 2034 年达到约 256 亿美元，高于 2024 年的 214 亿美元。

注册获取我们的每日新闻汇总！

Give your business an edge with our leading industry insights.

通过我们领先的行业洞察，为您的业务提供优势。

Medical Device Network Excellence Awards - Have you nominated?

医疗器械网络卓越奖——您提名了吗？

Nominations are now open for the prestigious

提名现已开放，迎接这一享有盛誉的奖项

Medical Device Network Excellence Awards

医疗器械网络卓越奖

- one of the industry's

- 行业中的